Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vesna Tripković is active.

Publication


Featured researches published by Vesna Tripković.


BMJ Open | 2014

Unusually low prevalence of Mycoplasma genitalium in urine samples from infertile men and healthy controls: a prevalence study

Vanda Plečko; Lidija Zele-Starcevic; Vesna Tripković; Mihael Skerlev; Suzana Ljubojević; Sanja Pleško; Ivana Mareković; Jørgen Skov Jensen

Objective To detect Mycoplasma genitalium in urine samples of infertile men and men without any signs of infection in order to investigate whether M. genitalium and other genital mycoplasmas (Mycoplasma hominis and Ureaplasma spp) are found more often in urine samples of infertile men than in asymptomatic controls and to determine resistance to macrolides. Methods The study included first void urine samples taken from 145 infertile men and 49 men with no symptoms of urethritis. M. genitalium, Chlamydia trachomatis and Neisseria gonorrhoeae were detected by commercial PCR. Trichomonas vaginalis was detected by microscopy and culture. M. hominis and Ureaplasma spp were detected by culture. M. genitalium was detected by in-house conventional and real-time PCR. Results Two M. genitalium positive samples were found among samples obtained from infertile men. All asymptomatic men were M. genitalium negative. Macrolide resistance was not found in either of the two positive samples. Conclusions In comparison with reported data, an unusually low prevalence of M. genitalium was found in infertile men. The reasons for this unexpected result are not known; possibly, local demographic and social characteristics of the population influenced the result. Further studies to investigate M. genitalium in infertile and other groups of patients are needed.


Chemotherapy | 1998

Helicobacter pylori: In vitro Induction of Resistance to Azithromycin

Smilja Kalenić; Vanda Plečko; Sanja Krešić; Vladimir Presečki; Vesna Tripković; Lidija Žele-Stračević; Mirjana Katičić; Mara Dominis

Helicobacter pylori resistance to macrolides is possibly an important factor for the failure of macrolide therapy for H. pylori infection. The aim of this study was to assess the propensity of H. pylori to develop in vitro resistance to azithromycin. In 73 clinical isolates taken from patients before starting antimicrobial therapy of H. pylori infection, MIC was determined using an agar dilution method (Müller-Hinton agar with 7.5% unlysed horse blood, pH = 7.2, at 35°C, during 72 h in a humid microaerobic atmosphere). Each strain was first cultivated at half minimal inhibitory concentration (MIC) then in doubling concentrations until growth arrest. All experiments for induction of resistance were performed on the same media, incubation temperature, atmosphere and time of MIC determination. MIC interpretative standards for sensitivity, intermediate sensitivity and resistance of H. pylori to azithromycin were ≤2, 4 and ≥8 mg/l, respectively. Of 73 strains, 5 died during the experiments, and in the remaining 68 strains, serial passage with increasing azithromycin concentrations resulted in the development of resistance in 19 (26.9%) strains. Two strains had an MIC of 16 mg/l azithromycin. Thirty-three (48.5%) strains kept the same MIC or doubled their MIC, 16 (23.5%) strains had 4- to 16-fold MIC but still remained sensitive, 2 resistant strains had 128-fold MICs and 17 resistant strains had increased their MICs more than 128 times. Seventeen highly resistant strains (MIC >128 mg/l) were kept frozen at –70°C for 3 months in a brain-heart infusion broth with 15% glycerol. MIC was assessed again to determine the stability of resistance. Eleven strains kept MICs >128 mg/l, 2 became sensitive and 1 intermediate, but reverted easily, after only 2 passages, to an MIC of >128 mg/l azithromycin. Although macrolides are very active against H. pylori, the propensity to develop resistance in a high proportion of strains has a clear impact on the choice of the right combinations of macrolides with other agents as well as the dosage of the macrolide antibiotics.


Croatian Medical Journal | 2008

Impact of Aminoglycoside Cycling in Six Tertiary Intensive Care Units: Prospective Longitudinal Interventional Study

Igor Francetić; Smilja Kalenić; Mirjana Huić; Iveta Merčep; Ksenija Makar-Aušperger; Robert Likić; Viktorija Erdeljić; Vesna Tripković; Petra Simic


Acta Dermatovenerologica Croatica | 2013

Mycoplasma genitalium: Clinical Significance and Diagnosis

Vanda Plečko; Lidija Žele Starčević; Vesna Tripković; Violeta Rezo Vranješ; Mihael Skerlev


XXIVth International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer | 2012

Primary resistance of Helicobacter pylori to macrolides and metronidazole in the northern part of Croatia

Vanda Plečko; Miroslava Katičić; Dijana Varda Brkić; Vesna Tripković; Lidija Žele Starčević


Eccmid2017, abstracts online library | 2018

In vitro synergy and postantibiotic effect of colistin combined with meropenem against Enterobacteriaceae with multiple carbapenem resistance mechanisms

Branka Bedenić; Nataša Beader; Sonja Frančula Zaninović; Dijana Varda-Brkić; Vesna Tripković; Dorotea Šija; Marko Čačić; Ana Benčić; Amarela Lukić-Grlić; Ivan Barišić; Domagoj Slačanac; Mirna Vranić-Ladavac; Sanda Sardelić; Mario Sviben


ESCMID eLibrary - 28th European Congress of Clinical Microbiology and Infectious Diseases | 2018

Epidemic diffusion of OXA-48 beta-lactamase in Croatia

Branka Bedenić; Mia Slade; Sanda Sardelić; Mirna Vranić-Ladavac; Vlasta Zujić Atalić; Maja Bogdan; Ines Jajić; Domagoj Drenjančević; Marina Bubonja; Maja Tomić-Paradžik; Amarela Lukić Grlić; Vesna Tripković; Žele-Starčević. Lidija; Marija Gužvinec; Tatjana Tot; Dijana Varda Brkić; Arjana Tambić Andrašević


Singa Vitae | 2016

Role of Helicobacter pylori infection in intensive care unit

Dijana Varda-Brkić; Vesna Tripković; Lidija Žele Starčević; Branka Bedenić


26th European Congress of Clinical Microbiology and Infectious Diseases | 2016

The dupA genes in Helicobacter pyloriand their relationship with gastroduodenal diseases in North-west Croatia

Dijana Varda-Brkić; Aleksandra Presečki-Stanko; Lidija Žele-Starčević; Vesna Tripković; Ivana Mareković; Sonja Frančula-Zanović; Branka Bedenić


SignalVitae | 2015

Acinetobacter baumannii - mikrobiološke i fenotipske karakteristike izolata u Zavodu za intezivnu medicinu KBC Zagreb over a four years period

Dijana Varda-Brkić; Aleksandra Presečki-Stanko; Sanja Pleško; Vesna Tripković; Branka Bedenić

Collaboration


Dive into the Vesna Tripković's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marija Jandrlić

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar

Dijana Varda Brkić

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge